Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.


The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2022/2023. 

Press releases

LinKinVax introduces its Scientific Advisory
Board with the appointment of three leading
experts in immunology and epidemiology

LinKinVax welcomes interim results of the ANRS
VRI06 Phase I trial evaluating a novel HIV vaccine

Interested in our project?